X-Therma's $22.4M Series B Sets Stage to Transform Regenerat

/PRNewswire/ -- X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an...

Related Keywords

Pennsylvania , United States , Austria , Xiaoxi Wei , Jim Greenwood , Drug Administration , Biotechnology Innovation Organization , Sourcex Therma Inc , X Therma Inc , Breakthrough Device , Gene Therapy , Chief Executive Officer , Starling Locke Capital , Managing Director , Eighth Congressional District , Advancing Regenerative Medicine , Turnkey Solution , Setting New Standards , Organ Transport Device , Breakthrough Device Designation , San Francisco Bay Area ,